NXGLW | NEXGEL, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.8000 - 0.8000
52 Week Range	0.8000 - 0.8000
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	1,035
Average Volume	N/A
Shares Outstanding	34,878,699
Market Cap	38,524,590
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	N/A

Valuation
Profitability
Growth
Health
P/E Ratio	-0.58
Forward P/E Ratio	N/A
EPS	-1.39
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	19
Country	USA
Website	NXGLW

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It provides facemasks, undereye patches, blister shield foot care, hexagel, cracked heel repair patches, and fever patch. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was founded in 1997 and is based in Langhorne, Pennsylvania.

NXGLW's peers: IVDAW, NXGL, NLSPW, NRSNW, KTTAW, CINGW, NXLIW

*Chart delayed

Analyzing fundamentals for NXGLW we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see NXGLW Fundamentals page.

Watching at NXGLW technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on NXGLW Technicals page.